Michael S. Diamond

Affiliations: 
Washington University, Saint Louis, St. Louis, MO 
Google:
"Michael Diamond"
Mean distance: 16.92 (cluster 11)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Suryadevara N, Shiakolas AR, VanBlargan LA, et al. (2022) An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer. The Journal of Clinical Investigation
Doyle MP, Genualdi JR, Bailey AL, et al. (2022) Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever Virus. Mbio. e0051222
Hunt AC, Case JB, Park YJ, et al. (2022) Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice. Science Translational Medicine. eabn1252
Peng L, Hu Y, Mankowski MC, et al. (2022) Monospecific and bispecific monoclonal SARS-CoV-2 neutralizing antibodies that maintain potency against B.1.617. Nature Communications. 13: 1638
Hauser BM, Sangesland M, St Denis KJ, et al. (2022) Rationally designed immunogens enable immune focusing following SARS-CoV-2 spike imprinting. Cell Reports. 38: 110561
Kafai NM, Williamson LE, Binshtein E, et al. (2022) Neutralizing antibodies protect mice against Venezuelan equine encephalitis virus aerosol challenge. The Journal of Experimental Medicine. 219
Kawaoka Y, Uraki R, Kiso M, et al. (2022) Characterization and antiviral susceptibility of SARS-CoV-2 Omicron/BA.2. Research Square
Georgiev GI, Malonis RJ, Wirchnianski AS, et al. (2022) Resurfaced ZIKV EDIII nanoparticle immunogens elicit neutralizing and protective responses in vivo. Cell Chemical Biology
Cobb RR, Nkolola J, Gilchuk P, et al. (2022) A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in cynomolgus macaques. Med (New York, N.Y.)
Chong Z, Karl CE, Halfmann PJ, et al. (2022) Nasally-delivered interferon-λ protects mice against upper and lower respiratory tract infection of SARS-CoV-2 variants including Omicron. Biorxiv : the Preprint Server For Biology
See more...